(Nasdaq: KPTI) Karyopharm tx "catching a falling knife"
Recently FDA released data suggesting KPTI and myloma medicationi was too "Toxic" their MM chemo drug had SERIOUS toxicity AEs and even DEATH. Cohort of 123 pts ~86% had some sort of serious AE and ~24% dropped out because of this. to find out more about what happened and why SP dropped, see synopsis in the link below.
Synopsis of Data can be found here- opening bell 2/25/2018:
msmoneymoves.com/
NDA application: -// Failed*
fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM631806.pdf
Synopsis of Data can be found here- opening bell 2/25/2018:
msmoneymoves.com/
NDA application: -// Failed*
fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/OncologicDrugsAdvisoryCommittee/UCM631806.pdf
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.